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Abstract
Background: Several studies demonstrate that neurogenesis may be induced or activated following vascular
insults, which may be important for neuronal regeneration and functional recovery. Understanding the cellular
mechanism underlying stroke-associated neurogenesis is of neurobiological as well as neurological/clinical
relevance. The present study attempted to explore potential homing and early development of transplanted bone
marrow stem cells in mouse forebrain after focal occlusion of the middle cerebral artery, an experimental model of
ischemic stroke.
Results: Bone marrow stem cells isolated from donor mice were confirmed by analysis of surface antigen profile,
and were pre-labeled with a lipophilic fluorescent dye PKH26, and subsequently transfused into recipient mice with
middle cerebral artery coagulation. A large number of PKH26-labeled cells were detected surrounding the infarct
site, most of which colocalized with immunolabelings for the proliferating cell nuclear antigen (PCNA) and some
also colocalized with the immature neuronal marker doublecortin (DCX) during 1-2 weeks after the bone marrow
cells transfusion.
Conclusions: The present study shows that transplanted bone morrow cells largely relocate to the infarct penumbra
in ischemic mouse cerebrum. These transplanted bone marrow cells appear to undergo a process of in situ
proliferation and develop into putative cortical interneurons during the early phase of experimental vascular injury.
Background
Cerebral strokes due to ischemic, embolic and hemorrha-
gic insults are common neurological conditions that cause
brain damage and functional loss. Associated with or sub-
sequent to these insults are broad host responses at mole-
cular and cellular levels involving both the neuronal and
non-neuronal components of the brain. For instance,
stroke-related anatomical/pathological changes may
include infiltration of blood cells, angiogenesis and activa-
tion/proliferation of glial cells [1-3]. In addition, recent
studies indicate that neurogenesis may be induced or acti-
vated following vascular insults, which may be important
for neuronal regeneration and functional recovery [3-7].
Thus, understanding the cellular mechanism(s) underlying
stroke-associated neurogenesis is of neurobiological as
well as neurological/medical implications.
One of the key issues related to stroke-induced neuro-
genesis concerns the origin of cells that may give rise to
new neurons. It is currently considered that neurogenesis
in the adult brain occurs in restricted areas under physio-
logical conditions, namely the subventricular zone (SVZ)
and subgranular zone (SGZ) [8,9]. However, stroke and
trauma-induced neurogenesis have been described in
broad brain regions/sites than the SVZ/SGZ [10-14]. Of
interest, bone marrow cells may differentiate into various
types of peripheral cells and likely neurons as well
[15-17]. There is evidence from humans and laboratory
animals that new neurons in the brain may arise from
putative blood-borne cells [18,19]. It appears that puta-
tive bone marrow cells may be particularly important for
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injury [1,20]. Less is known with regard to the seeding
and early phase of proliferation or neuronal differentia-
tion of bone marrow cells in the stroke-injured brain. To
address these issues, we isolated bone marrow mononuc-
lear cells (BMMCs) from adult mice, pre-labeled them
with a lipophilic red fluorescence dye PKH26 [21], and
tracked these cells in vivo following transfusion into mice
with middle cerebral coagulation. We detected colocali-
zation around the infarct site of PKH26-labeled cells with
the endogenous cell division marker, proliferating cell
nuclear antigen (PCNA), and with the immature neuro-
nal marker doublecortin (DCX) [22,23]. These data
appear to support that bone marrow cells may be one of
the important sources of stem cells involved in neurogen-
esis following acute cerebral vascular injury, and that
transplantation of these cells is of potential clinical utility
in the management of stroke.
Results
Cytofluorometric characterization of bone marrow cell
preparations
Four fluorescence-activated cell sorting (FACS) analyses
were used to determine the expression of various signature
antigen markers of mesenchymal stem cells on the isolated
cells (Figure 1). In brief, 9.67% of the isolated cells
expressed CD34 (Figure 1A); 53.90% expressed CD44
(Figure 1B); 27.25% expressed stem cell marker, Sca-1 (Fig-
ure 1C); and 60.04% expressed CD45 (Figure 1D). Taken
together, the data implicated that the isolated bone mar-
row cells exhibited a panel of surface antigens characteris-
tic of the haemopoietic stem cell population [24]. In other
words, the bone marrow cells derived from BALB/c mouse
long bones appeared to be largely BMMCs according to
established evaluation protocols [25,26].
Distribution of transplanted bone marrow cells around
cerebral infarct
In the present study we established focal cerebral ischemia/
infarction under visually guided local occlusion of cerebral
artery. To confirm the effect of unilateral electric coagula-
tion of the middle cerebral artery, a group of animals were
sacrificed 6 hours after the surgery, and their brains were
removed without perfusion and were cut in ~3 mm thick
coronal slices (Figure 2A-C). Gross appearance of focal
ischemia was evident in the operated hemisphere, with a
pale infarct area located around the lateral-middle portion
of cerebrum. In H.E. stained sections from these brains,
signs of tissue necrosis were present in and around the
infarct, including vacuolation, shrunken neurons and eosi-
nophilic cytoplasm (Figure 2D, E).
In our pilot studies, we looked PKH26 fluorescent sig-
nal 1 to 4 weeks post bone marrow cells transplantation
in the ischemic and control brains. Fluorescent cells
were detectable in the former group up to ~3 weeks,
but tended to fade afterwards (data not shown). In nor-
mal control brain, only a very few fluorescent cells were
encountered (data not shown), suggesting increased
infiltration of blood cells after vascular injury. For these
reasons, histological and immunohistochemical analyses
were carried out at 1 and 2 weeks post cell transplant.
Thus, at the one week surviving time point, a large
number of PKH26-labeled cells were found in the
ischemic brains, which were located primarily around
the border of the infarct area and the peripheral healthy
regions in the cortex, or the infarct penumbra (Figure
2F). These cells were small in size and appeared often in
group or cluster (Figure 2G). No apparent cellular pro-
cesses were visible on these cells. In all examined brain
sections from animals received PBS as vehicle control,
no PKH26-labeled cells were found (Figure 2H).
Colocalization of transplanted bone marrow cells with
PCNA
Immunolabeling for the proliferating cell nuclear anti-
gen (PCNA) was used to detect in situ cell proliferative
activity in the ischemic mouse cortex. A large number
of PCNA immunoreactive nuclei were present at the
junction of the infarct site to the peripheral, relatively
healthy, areas at 1 (Figure 2I) and 2 (not shown) weeks
post cerebral artery occlusion. Fewer labeled cells were
also seen interior to this border (i.e., towards the infarct
center) (Figure 2I, J). PCNA immunoreactive profiles
were all cell nuclei as confirmed by haematoxylin coun-
terstain, and they exhibited variable labeling intensity
and sizes. In addition, some of PCNA labeled nuclei
appeared to occur in pair (Figure 2I, small arrows).
In order to explore if transplanted bone marrow cells
might be a part of the proliferating cells seen around the
infarct areas, we carried out double labeling analysis for
colocalization of PCNA (visualized with Alexa-488 conju-
gated secondary antibody) and PKH26. In the brains
examined 1 week after bone marrow cell transplant, most
PKH26-labeled cells were found to colocalize with PCNA
(Figure 3A-D) immunoreactivity. Similar to the above
described distribution of cells labeled by PKH26 or
PCNA, the double-labeled cells occurred predominantly
around the infarct penumbra. Many of the double-labeled
cells appeared in pair or in small cluster, optimal for a
morphochemical pattern of actively proliferating cells
(Figure 3C, D).
Colocalization of transplanted bone marrow cells with
doublecortin
Doublecortin (DCX) is an immature neuronal marker
expressed by newborn neurons in the subventricular and
subgranular zones in the adult mammalian brain [23].
DCX labeling can be used to detect recently-generated
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brain including the cerebral cortex [3,14]. We used this
marker to explore if transplanted bone marrow cells
might differentiate toward neuronal phenotype in the
ischemic mouse cerebral cortex. In double fluorescent
preparations, we did not detect clear colocalization of
DCX among PKH26-labeled cells at 1 week post bone
marrow cell transplant (data not shown). However, in
sections from animals survived for two weeks, some
PKH26-labeled cells appeared to colocalize with DCX.
These double-labeled cells were again found around the
infarct penumbra. Some of the double-labeled cells had
relatively large somal size with visible dendrite-like pro-
cesses, suggestive of a neuronal morphology (Figure 3F).
Among the colocalized cells, those with larger somata
expressed weaker PKH26 fluorescence relative to the
ones with smaller size (Figure 3E). Thus, there appeared
to be a trend of reduction or dilution of PKH26 labeling
with cell growth. Overall, the morphology of the double-
labeled cells resembled interneurons rather large
pyramidal neurons in the cerebral cortex [14]. In longer
surviving time point (3-4 weeks), we failed to detect dou-
ble-labeled cells likely because of the fading of PKH26
fluorescence with time (not shown).
Discussion
Significant advance has been made during recent years
in the field of stem cell therapy [27,28]. Because pluripo-
tent bone marrow stem cells can be obtained from a
given individual and transplanted in a form of autograft
following potential in vitro expansion, these cells are
considered to be of particular medical use for tissue/
organ repair [15,16,29]. In many peripheral organs,
transplantation of bone marrows stromal cells appear to
facilitate tissue regeneration and improve functional
recovery following acute injury and even under certain
chronic degenerative conditions [17,26,30-34]. Bone
marrow stem cells are also considered to be useful in
the treatment of acute brain injury and certain degen-
erative neurological disorders [17,28]. In animal models
Figure 1 Fluorescence-activated cell sorting analyses the expression of mesenchymal stem cell markers. APC-conjugated anti-mouse
CD34 reactivity is detected on 9.67% of the isolated cells (A). PE-conjugated anti-mouse/human CD44 reactivity is present on 53.90% of the cells
(B). Percp-conjugated anti-mouse CD45 antibody labels 60.04% of the cells (C), and FITC-conjugated anti-mouse LY-6A/EC Sca-1 antibody reacts
to 27.25% of the cells (D).
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coronal cerebral slices showing the impact of occlusion 6 hours post-occlusion, with the infarct appearing as pale area marked with broken line.
Hematoxylin and eosin (H.E.) stain illustrates loss of relatively large cells and infiltration of small cells at the border of the infarct (D). Paired
cellular profiles are seen peripheral to the infarct border or the infarct penumbra (E). At low magnification, a large number of transplanted bone
marrow cells pre-labeled by PKH26 (red fluorescence) are present in the infarct penumbra 7 days post lesion (F). The labeled cells are small and
may occur in cluster (G). No fluorescent cells exist in the cerebral cortex of mice received vehicle infusion (H). In situ cell division reflected by
immunoreactivity of proliferating cell nuclear antigen (PCNA) occurs predominantly at the infarct border (I) and penumbra (J), appearing as
brown immunoreactive nuclei in hematoxylin counter-stained section.
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Page 4 of 9Figure 3 Identification of PKH26-labeled cells with proliferating cell nuclear antigen and doublecortin after transplantation.
Colocalization of PKH26-labeled bone marrow cells with proliferating cell nuclear antigen (PCNA) (A-D) and doublecortin (DCX) (E-G) around the
infarct penumbra 7 and 14 days following transplantation. PKH26 and PCNA double-labeled cells are small and occur in pair or small cluster (C,
D). PKH26 and DCX double-labeled cells have round or oval somata with visible neuronal processes. PKH26 fluorescence appears weaker in these
double-labeled cells relative to those seen at 7 days post cell transplantation. Scale bar (in B) = 200 μm for A, B and 50 μm for C-G.
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therapy show beneficial effects, as evidenced by
improved histological outcome and neurological perfor-
mance [35-37].
Evidence exists in supportive of an involvement of
putative blood-borne cells, likely stromal stem cells, in
neurogenesis in mature mammalian brain. In humans as
well as animals, mature neurons containing Y-
chromosome are detected in the cerebrum of females
that have received blood from males [18,19]. It appears
that bone marrow stem cells might contribute to adult
neurogenesis more significantly following brain injury.
A number of previous studies report that transplanted
bone marrow cells pre-labeled with BrdU or retrovirus
colocalize with mature neuronal (also glial and endothe-
lial) markers, such as MAP-2 and NeuN, in the cere-
brum following ischemic injury [35,38-40]. However,
few studies have investigated the early stage of develop-
ment or transdifferentiation of the transplanted bone
marrow cells in injured host brain.
I nt h ep r e s e n ts t u d y ,b o n em a r r o wc e l l sa r ei s o l a t e d
from adult mouse long bone, and are subsequently charac-
terized using a panel of haemopoietic stem cell markers.
The isolated bone marrow cells express CD34 (9.67%),
CD44 (53.90%), Sca-1 (27.25%) and CD45 (60.04%), there-
fore confirming a phenotype of mesenchymal stem cells.
Then, a lipophilic marker PKH26 is used to pre-label the
isolated bone marrow stem cells, which allow us to track a
large population of these cells in vivo for a few weeks fol-
lowing transplantation. In the ischemic mouse cerebral
cortex, most of the PKH26-labeled bone marrow stem
cells are localized to the periphery or the penumbra of
ischemic infarct. This distribution pattern suggests that
the cells are likely released from the blood vessels of the
neighboring healthy cortex, or alternatively that the cells
survive better around the infarct penumbra because of a
relatively intact blood supply. Of note, we observe a con-
siderable amount of proliferative activity in the same peri-
infarct region, as reflected by PCNA expression. Moreover,
there exists a great degree of colocalization between
PCNA and PKH26 around the infarct penumbra. There-
fore, the transplanted bone marrow stem cells might
undergo in situ proliferation after they have seeded in the
ischemic cerebral parenchyma.
Importantly, by two weeks post transfusion many
PKH26-labeled cells in the peri-infarct region colocalize
with DCX, a marker of immature neurons [23]. The dou-
ble-labeled cells are relatively small, have round or oval
somata, and develop dendrite-like processes. The morphol-
ogy of these double-labeled cells is more reminiscent of
cortical interneurons rather than pyramidal neurons.
A previous study also shows that bone-marrow cell derived
neurons exhibit stellate, ramified or triangular morpholo-
gies [39]. Another study demonstrates that newborn
neurons in ischemic rat cortex co-express various markers
of cortical interneurons [14]. Thus, our findings are consis-
tent with a notion that the transdifferentiated neurons
from bone-marrow cells in the injured cerebrum are mor-
phologically resembled cortical interneurons.
Conclusions
In summary, following in vitro labeling of a large num-
ber of cells with the lipophilic marker PKH26, the pre-
sent study demonstrates that transplanted bone morrow
cells relocate to and reside mostly around the infarct
penumbra in a mouse model of ischemic cerebral stroke.
These transplanted bone marrow cells might undergo
certain extent of in situ proliferation, and they appear to
transdifferentiate into putative cortical neurons during
the first few weeks of experimental vascular injury.
Methods
Experimental animals
BALB/c mice at 8 to 10 weeks of age, either sex, weighing
20 to 22 grams, were purchased from the Animal Center
of Second Affiliated Hospital of Harbin Medical Univer-
sity. Animals were housed at constant temperature and
humidity, with a 12/12 hr light/dark illumination cycle
and free access to food chow and water. All experimental
procedures used in the present study were approved by
the Harbin Medical University Administrative Panel on
Laboratory Animal Care, which is compatible with the
NIH guidelines for use and care of laboratory animals.
Reagents
The primary antibodies and detecting reagents included
mouse anti-PCNA antibody (BM0104, Boster company,
Santa Cruz Biotechnology), goat-anti-doublecortin (SC-
8006, Boster company, Santa Cruz Biotechnology), Alexa
Fluor® 488 and 594 conjugated donkey anti-mouse and
anti-goat IgGs (Invitrogen, Carlsbad, CA). The fluores-
cent dye PKH26 was obtained from Sigma-Aldrich
(MINI26, Saint louis, Missouri, USA). All fluorescent
cytoflow markers were purchased from Biolegend (San
Diego, USA), including (FITC rat IgG 2 Isotype ctrl.
Clone: RT K 2758 (Cat. No. 400505), APC rat IgG 2 Iso-
type ctrl. Clone: RT K 2758 (400511), Percp rat IgG 2b
Isotype ctrl. Clone: RT K 2758 (118419), PE rat IgG 2b
Isotype ctrl. Clone: RT K 2758 (119316), APC anti-
mouse CD34 Clone: MEC 14.7 (119309), FITC anti-
mouse LY-6A/EC Sca-1 Clone: E13-16.1.7 (122505), PE
anti-mouse/human CD44 Clone: IM 7 (103007), Percp
anti-mouse CD45 Clone: 30-F11 (103129).
Isolation and lipophilic fluorescent labeling of bone
marrow cells
BALB/c mice were anesthetized with sodium pentobar-
bital (100 mg/kg, i.p.). Femoral bones were removed
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by heparin (50 U/mL) in normal saline [41,42]. Bone
marrow was aspirated and suspended in a lymphocyte
isolation medium, followed by centrifuge at 2000 rpm
for 20 minutes. The cell pellets were subsequently
diluted with DMEM/F12 medium (DMEM/F12, 15%
FBS, 100000 U/L penicillin, pH = 7.4) to yield a density
of more than 5×10
7 cells/mL. The cells were then
labeled with the red-fluorescent lipophilic tracer PKH26
according to the manufacturer’s instruction [41]. The
density of PKH26-labeled cell suspension was adjusted
to approximately 3×10
7 cells/mL. Cells with viability
greater than 95% as measured by trypan blue exclusion
were used for the subsequent transplant studies.
Focal cerebral ischemia and bone marrow cell transfusion
An acute ischemic stroke model was established by coagu-
lation of the middle cerebral artery in experimental mice
[2]. In brief, mice were anesthetized with pentobarbital
(50 mg/kg, i.p.), and a craniotomy was carried out by
maintaining the animals over a heating pad (with rectal
temperature at 36.5 to 37.5°C). The left middle cerebral
artery (MCA) was exposed, and occluded with a short
period of coagulation using a general metallic heat applica-
tor. The cranial hole was sealed with dental cement, and
skin sutured before the mice were returned to their cages.
After the brain surgery, the experimental animals were
infused via tail vein either with PKH26 pre-labeled bone
marrow cells (n = 16) or phosphate buffered solution
(PBS) as control (n = 16). Animals were allowed to survive
for 6 hours (n = 4), and 7 (n = 4), 14 (n = 4) and 21
(n = 4) days post bone marrow cell transplantation.
Fluorescence-activated cell sorting analysis
To evaluate the purity of the isolated bone marrow cells
as putative bone marrow mononuclear cells (BMMCs) or
bone marrow stem cells, part of the cell pellet was subject
to fluorescence-activated cell sorting (FACS) analysis for
the expression of various signature antigen markers of
mesenchymal stem cells. Thus, approximately 1×10
6 cells
were incubated in 2% fetal bovine serum in PBS at 4°C
for 30 minutes with 1 μl of monoclonal antibody specific
for CD34, CD44, CD45, Sca-1 (all from BioLegend 11080
Roselle Street, San Diego, CA 92121). Negative control
was processed by incubating the cells in buffer without
primary antibodies. The immunofluorescent signal was
analyzed using the FACS Calibur with CellQuest software
(Becton Dickinson, USA).
Tissue preparation
Except for the short time surviving group (6 hrs post
surgery), all other animals were perfused transcardially
with 4% paraformaldehyde (Sigma-Aldrich, St. Louis,
USA) in 0.01 M phosphate-buffered saline (pH 7.4, PBS)
under overdose anesthesia (sodium pentobarbital
100 mg/kg, i.p.). Brains were removed from the skull,
postfixed in the perfusion fixative overnight, and cryo-
protected in 30% sucrose at 4°C. Brains were cut at the
coronal plane in a cryostat at 6 μm, and sections passing
through the infarct areas were collected alternatively
(every 20 sections) by thaw-mounting on gelatin-coated
microslides. Sections were stored at -70°C for a few
weeks before histological (H.E stain) and immunohisto-
chemical examinations.
Immunohistochemistry
For immunolabeling with the peroxidase method, sec-
tions were first treated 1% H2O2 in PBS for 30 minutes,
and then pre-incubated in 5% normal horse or rabbit
serum in PBS with 0.3% Triton X-100 for 1 hour. Sub-
sequently, sections were incubated with mouse anti-
PCNA (1:400) or goat anti-DCX (1:100) antibodies in
PBS containing the blocking serum and Triton X-100 at
4°C overnight. Sections were further reacted with bioti-
nylated horse anti-mouse or rabbit anti-goat secondary
antibodies at 1:400 (BM0104 Boster company, Santa
Cruz Biotechnology, CA) for 2 hours, and finally with
the avidin-biotin complex (ABC) reagents (1:400) (Vec-
tor Laboratories, Burlingame, CA) for another 1 hour.
Immunoreation product was visualized in 0.003% H2O2,
0.05% diaminobenzidine (DAB; Sigma, St, Louis, MO).
Three 10-minute washes were used between all incuba-
tions. Sections were allowed to air-dry, dehydrated
through ascending ethanol, cleared with xylene and cov-
erslipped. Some of the above immunohistochemically
prepared sections were counterstained with haematoxy-
lin before dehydration.
To determine the colocalization of PCNA and DCX
expression with transplanted BMMCs, additional sec-
tions were subject to double fluorescent labeling for
PCNA or DCX with PKH26. Sections were incubated in
PBS containing 5% normal donkey serum and mouse
anti-PCNA antibody (1:400) or goat anti-DCX antibody
(1:200) at 4°C overnight, followed by a 2 hours reaction
with Alexa Fluor® 488 conjugated donkey anti-mouse or
goat IgGs (1:200, A21206 Invitrogen, Carlsbad, CA).
Sections were then washed and mounted with anti-fad-
ing medium before microscopic examination. Sections
from animals received tail vein infusion of the PBS vehi-
cle were processed in parallel as negative control for
fluorescent labeling.
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